INTERIM RESULTS

RNS Number : 8902H
Sagentia Group PLC
18 July 2012
 



 

 


18 July 2012

 

SAGENTIA GROUP PLC

 

("Sagentia" or the "Group")

 

INTERIM RESULTS

FOR THE SIX MONTH PERIOD ENDED 30 JUNE 2012

 

Sagentia Group plc is an international technology consulting company providing outsourced R&D consultancy services from market analysis, through product development to transfer-to-manufacture for the medical and commercial sectors.

 

Summary:

 

·  

Good operating performance despite more difficult market conditions

·  

Revenues of £10.7 million (H1 2011: £12.6 m; H2 2011: £11.0 m)

·  

Consulting fees of £8.6 million (H1 2011: £9.7 m; H2 2011: £8.4 m)

·  

Operating profit of £2.0 million (H1 2011: £2.3 m; H2 2011: £1.7 m)

·  

PBT of £1.8 million (H1 2011: £2.0 m; H2 2011 of £1.3 m)

·  

Basic EPS of 4.6 pence (H1 2011: 4.9 pence; H2 2011: 2.9 pence)

·  

NAV per share of 66.9 pence (30 June 2011: 59.2 pence)

·  

Cash balance increased to £18.9 million (30 June 2011: £17.7 m) and net funds of £12.3 million (30 June 2011: £10.1 m), after share buy-back cost of £2.4 million

 

Enquiries:

Sagentia Group plc


Martyn Ratcliffe, Chairman


Brent Hudson, Chief Executive

Tel: +44 (0) 1223 875 200

Neil Elton, Finance Director

www.sagentia.com

 

Numis Securities Limited


Nominated Adviser: Oliver Cardigan / Simon Willis

Corporate Broking: James Serjeant

Tel: +44 (0) 20 7260 1000

 

Media enquiries:

Abchurch


Henry Harrison-Topham / Jamie Hooper

Tel: +44 (0) 20 7398 7719

jamie.hooper@abchurch-group.com

www.abchurch-group.com



Interim Results 2012

 

Group Financial Performance

 

Despite more difficult market conditions, Sagentia reports a very satisfactory operating performance for the six months ended 30 June 2012.  The business process changes introduced during the turnaround phase over the past two years have proven effective and have enabled Sagentia to ride through the more turbulent environment since the middle of 2011.  As a result, Sagentia has delivered very strong operating margins of 19% on reduced revenue.

 

For the six months ended 30 June 2012, the Group generated operating profit of £2.0 million (H1 2011: £2.3 million; H2 2011: £1.7 million) on revenue of £10.7 million (H1 2011: £12.6 million; H2 2011: £11.0 million).  Profit before tax of £1.8 million (H1 2011: £2.0 million; H2 2011: £1.3 million) represents a margin of 17.0% (H1 2011: 16.0%; H2 2011: 12.1%).  The Group has substantial tax losses carried forward.  As noted last year, the comparable period in 2011 benefited from one-off product revenues and particularly high recharged project expenses.  The H1 2012 results reflect a stronger performance than in H2 2011, with profit margins increasing due to tight cost control and reduction in the use of third party resources.  The Board considers that the reported operating margin level is towards the top-end of comparable companies in the industry. 

 

Consulting fees from Core operations were £8.6 million (H1 2011: £9.7 million; H2 2011: £8.4 million).  Other Core revenues of £0.7 million, which comprise product and licence income and recharged project material revenues decreased compared to H1 2011 (£1.5 million), as anticipated.  Other (non-Core) revenues have remained relatively consistent in 2012 compared to the same period in 2011, including property income from sub-let space in the Harston Mill facility where there are currently 12 tenants and minimal current vacant space.

 

In the period to 30 June 2012, approximately 59% of the Group's Core revenue was derived from the Medical Sector (H1 2011: 72%) and 41% from the Commercial Sector (H1 2011: 28%).  North America, the Group's largest international market contributed 63% of Group Core revenue (H1 2011: 65%).  The top five clients accounted for approximately 40% and the top ten clients for approximately 65%, of the Core revenues (H1 2011: 51% and 69% respectively).  The changes in revenue profile reflect the suspension of a large Medical sector project in North America earlier this year offset by a recovery in the Commercial sector  which benefitted from the multi-year outsourced R&D contract signed in September 2011.



 

Following the AGM in April 2012, the Company has acquired 2,938,000 of its own shares for £2.4 million in a share buyback at an average price of 80.8 pence per share.  This has resulted in a net reduction in the issued Ordinary share capital (excluding treasury shares) of 7.0% from 41,841,095 to 38,921,480.  Diluted earnings per share in H1 2012 was 4.3 pence (H1 2011: 4.6 pence) with a basic earnings per share of 4.6 pence (H1 2011: 4.9 pence).

 

The Group has a robust balance sheet with Shareholder Funds at 30 June 2012 of £26.0 million (30 June 2011: £24.7 million), including net cash and freehold property of £26.0 million.  The resulting net asset value per share has increased by 13% to 66.9 pence per share (30 June 2011: 59.2 pence per share).  Cash increased to £18.9 million (30 June 2011: £17.7 million).  The main components to the cash movements over the past 12 months include operating cash flow of £3.6 million; receipts from the sale of investments in H2 2011 of £0.7 million; less funds paid as part of the share buyback (£2.4 million); bank loan repayments of £0.8 million; and settlement of the legacy Sagentia GmbH pension obligations (£0.3 million).  Net funds at 30 June 2012 were £12.3 million (30 June 2011: £10.1 million).

 

Prospects

 

In the first half of 2012 the Group has continued to perform very satisfactorily although,as a project-based science and technology consultancy, Sagentia is not immune to the macro-economic environment affecting its customers and sales processes have become more protracted.  However, the diversity of geography and sectors serviced by the Group provides some resilience which, combined with tight cost control and a reduction in the use of third-party resources, has enabled the Group to maintain strong operating margins.  The Board anticipates the market environment will remain unpredictable for the foreseeable future and will therefore maintain its prudent approach.

 

With a robust balance sheet and strong profitability, the Board continues to evaluate acquisition opportunities to accelerate the growth of the Group, although will remain cautious in considering any such transactions.  In addition, since the Group is now financially stable with consistently strong operating margins and cash flow, the Board is also considering increasing investment in developing intellectual property assets which could enhance shareholder value in the medium-term.  Furthermore, while the Group's market valuation remains only modestly above Net Asset Value, placing modest value on the highly profitable, cash generative operating business, the Board considers that further share buybacks may be an appropriate use of capital resources.



Consolidated Income Statement

For the period ended 30 June 2012

 


 

 

 

 

 

Notes

Six months

ended

30 June

2012

(Unaudited)

 

£000

Six months

ended

30 June

2011

(Unaudited)

 

£000

Year

ended

31 December

2011

(Audited)

 

£000






Revenue


10,651

12,564

23,568

Operating expenses


(8,602)

(10,314)

(19,662)






Operating profit

4

2,049

2,250

3,906

Net (loss) / gain on disposal of non-current asset investments


 

-

 

15

 

(80)

Share based payment charge


(123)

(104)

(206)

Profit before finance charges and tax

4

1,926

2,161

3,620

 

Finance costs

Finance income


 

(162)

45

 

(184)

39

 

(353)

79






Profit before income tax


1,809

2,016

3,346

Income tax credit / (charge)


72

20

(78)

Profit for the period from continuing operations

 

4

 

1,881

 

2,036

 

3,268

Loss for the period from discontinued activities


 

-

 

-

 

(680)






Profit for the period


1,881

2,036

2,588











Profit for the period attributable to:





Equity holders of the parent


1,881

2,036

2,588

Non-controlling interests


-

-

-

Profit for the period


1,881

2,036

2,588
















Earnings per share





Earnings per share (basic)

5

4.6p

4.9p

7.8p

Earnings per share (diluted)

5

4.3p

4.6p

7.3p

 



 

Consolidated Statement of Comprehensive Income

For the period ended 30 June 2012

 

 



Six months

ended

30 June

2012

(Unaudited)

 

£000

Six months

ended

30 June

2011

(Unaudited)

 

£000

Year

ended

31 December

2011

(Audited)

 

£000






Profit for the period


1,881

2,036

2,588

Other comprehensive income:

Exchange differences on translating foreign operations

Recycled translation reserve

 


 

 

(18)

-

 

 

(111)

-

 

 

258

680

Other comprehensive income for the period, net of tax


 

(18)

 

(111)

 

938

Total comprehensive income for the period


 

1,863

 

1,925

 

3,526

 

 










Attributable to:





Owners of the parent


1,863

1,925

3,526

Non-controlling interests


-

-

-

Total comprehensive income for the period


 

1,863

 

1,925

 

3,526



 

Consolidated Statement of Changes in Shareholders' Equity

For the period ended 30 June 2012

 

Group

 

 

Issued

capital

 

 

£'000

Share

premium

 

 

£'000

Treasury

Stock

 

 

£'000

Merger

reserve

 

 

£'000

Translation

reserve

 

 

£'000

Share based

payment

reserve

 

£'000

Retained

earnings

 

 

£'000

Total -

Shareholders

funds

 

£'000

Non-

Controlling

Interest

 

£'000

Total

equity

 

 

£'000

417

7,518

-

22,211

(680)

832

(7,551)

22,747

70

22,817

Change in ownership interest*

-

-

-

-

-

-

(80)

(80)

(70)

(150)

Share based payment charge

-

-

-

-

-

104

-

104

-

104

-

-

-

-

-

104

(80)

24

(70)

(46)












Profit for the period

-

-

-

-

-

-

2,036

2,036

-

2,036





















Exchange differences on translating foreign operations

 

-

 

-

 

-

 

-

 

(111)

 

-

 

-

 

(111)

 

-

 

(111)

 

-

 

-

 

-

 

-

 

(111)

 

-

 

2,036

 

1,925

 

-

 

1,925

417

7,518

-

22,211

(791)

936

(5,595)

24,696

-

24,696

 

 

417

7,518

-

22,211

(791)

936

(5,595)

24,696

-

24,696

Disposal of Sagentia Group AG

 

-

 

-

 

-

 

(11,868)

 

-

 

-

 

11,868

 

-

 

-

 

-

New shares issued

1

20

-

-

-

-

-

21

-

21

Share based payment charge

-

-

-

-

-

102

-

102

-

102

1

20


(11,868)

-

102

11,868

123

-

123












Profit for the period

-

-

-

-

-

-

552

552

-

552





















Exchange differences on translating foreign operations

 

-

 

-

 

-

 

-

 

369

 

-

 

-

 

369

 

-

 

369

  Recycled to income statement

-

-

-

-

680

-

-

680

-

680

 

-

 

-

 

-

 

-

 

1,049

 

-

 

552

 

1,601

 

-

 

1,601

 

418

 

7,538

 

-

 

10,343

 

258

 

1,038

 

6,825

 

26,420

 

-

 

26,420

 

 

418

7,538

-

10,343

258

1,038

6,825

26,420

-

26,420

Repurchase of own shares

-

-

(2,374)

-

-

-

-

(2,374)

-

(2,374)

New shares issued

1

12

-

-

-

-

-

13

-

13

Share based payment charge

-

-

-

-

-

123

-

123

-

123

1

12

(2,374)

-

-

123

-

(2,238)

-

(2,238)












Profit for the period

-

-

-

-

-

-

1,881

1,881

-

1,881





















Exchange differences on translating foreign operations

 

-

 

-

 

-

 

-

 

(18)

 

-

 

-

 

(18)

 

-

 

(18)

 

-

 

-

 

-

 

-

 

(18)

 

-

 

1,881

 

1,863

 

-

 

1,863

419

7,550

(2,374)

10,343

240

1,161

8,706

26,045

-

26,045

 

* On 14 January 2011 the Group purchased the remaining shares in Manage5Nines Limited held by third parties to give the Group a 100% interest.  The cash consideration was £150,000 which has been recorded to equity as a change in ownership interest in a subsidiary.



 

Consolidated Statement of Financial Position

At 30 June 2012

 



Six months

ended

30 June

2012

(Unaudited)

 

 

£000

Six months

ended

30 June

2011

(Unaudited)

 

 

£000

Year ended

31

December

2011

(Audited)

 

 

£000

Assets





Non-current assets





Property, plant and equipment


14,145

14,141

14,120

Deferred income tax assets


3,360

3,240

3,237



17,505

17,381

17,357

Current assets





Trade and other receivables


2,759

4,170

2,876

Cash and cash equivalents


18,905

17,714

21,198



21,664

21,884

24,074

  Non-current assets classified as held





  for sale





  Non-current assets classified as held for sale


-

802

-



-

802

-

  Total assets


39,169

40,067

41,431






Liabilities





Current liabilities





Trade and other payables


3,852

5,099

5,327

Current income tax liabilities


186

1

180

Other borrowings


831

835

835



4,869

5,935

6,342

Non-current liabilities





Borrowings


5,818

6,731

6,232

Other creditors


-

171

-

Deferred income tax liabilities


2,437

2,534

2,437



8,255

9,436

8,669

 Total liabilities


13,124

15,371

15,011






  Net assets


26,045

24,696

26,420






Shareholders' equity





Share capital


419

417

418

Share premium


7,550

7,518

7,538

Treasury stock


(2,374)

-

-

Merger reserve


10,343

22,211

10,343

Translation reserves


240

(791)

258

Share based payment reserve


1,161

936

1,038

Retained earnings


8,706

(5,595)

6,825



26,045

24,696

26,420

Non-controlling interest


-

-

-

 Total equity


26,045

24,696

26,420

 



 

Consolidated Statement of Cash Flows

For the period ended 30 June 2012

 


Six months

ended

30 June

2012

(Unaudited)

 

£000

Six months

ended

30 June

2011

(Unaudited)

 

£000

Year ended

31

December

2011

(Audited)

 

£000





Profit before income tax

1,809

2,016

3,346

  Depreciation and amortisation charges

115

116

231

  (Gain) / loss on disposal of non-current asset investments

 

-

 

(15)

 

80

Share based payment charge

123

104

206

(Increase) / decrease receivables

117

(83)

1,211

(Decrease) in payables

(1,475)

(329)

(347)

 Cash generated from operations

689

1,809

4,727





UK corporation tax (paid) (net)

(38)

(63)

(40)

Foreign corporation tax (paid) / received (net)

(7)

16

(20)

 Cash flows from operating activities

644

1,762

4,667









Purchase of property, plant and equipment

(132)

(145)

(239)

Purchase of subsidiary undertaking

-

(150)

(150)

Proceeds from sale of property, plant and equipment

 

-

 

-

 

-

Sale of current asset investments

-

238

944

 Cash flow from investing activities

(132)

(57)

555





Issue of ordinary share capital

13

-

21

Repurchase of own shares

(2,374)

-

-

Repayment of loans

(400)

(400)

(800)

Proceeds from other loans

-

90

95

Repayment of other loans

(18)

(6)

(28)

 Cash flows from financing activities

(2,779)

(316)

(712)









(Decrease) / increase in cash and cash equivalents in the period

 

(2,267)

 

1,389

 

4,510

Cash and cash equivalents at the beginning of the period

 

21,198

 

16,430

 

16,430

Exchange profit (loss) on cash

(26)

(105)

258

Cash and cash equivalents at the end of the period

 

18,905

 

17,714

 

21,198

 



 

Extracts from notes to the financial statements

 

1. General information

 

The financial information for the 6 months ended 30 June 2012 set out in this interim report is unaudited and does not constitute statutory accounts as defined in Section 434 of the Companies Act 2006.  The financial information included has been extracted from the 2011 Financial Statements of Sagentia Group plc.  The Group's statutory financial statements for the year ended 31 December 2011 have been filed with the Registrar of Companies.  The auditor's report on those financial statements was unqualified and did not contain a statement under Section 498(2) or Section 498(3) of the Companies Act 2006.

 

These un-audited interim results have been approved for issue by the Board of Directors on 16 July 2012.

 

The group and company financial statements of Sagentia Group plc for the year ended 31 December 2011 were prepared under IFRS and have been audited by Grant Thornton UK LLP. Copies of the Financial Statements are available from the company's registered office; Harston Mill, Harston, Cambridge, CB22 7GG and can be found on the company's website at www.sagentia.com.

 

Sagentia Group plc ('Sagentia' or 'Company') and its subsidiaries (together 'Sagentia' or 'Group') is a technology consulting and IP exploitation organisation.  Sagentia creates, develops and delivers business opportunities, products and services for its clients in the Medical, Industrial and Consumer industries.  Sagentia's facilities include offices and laboratories located in Europe in Cambridge and in the US in Boston.

 

The Company is the ultimate parent company in which results of all the Sagentia companies are consolidated.

 

The Company is incorporated in England and Wales and has its primary listing on the AIM Market of the London Stock Exchange (SAG.L).

 

 

2.  Accounting policies

 

The principal accounting policies applied in the preparation of these interim financial statements are unchanged from those set out in the financial statements for the year-ended 31 December 2011.  These policies have been consistently applied to all the periods presented.

 

2.1 Basis of preparation

 

These interim consolidated financial statements are for the six months ended 30 June 2012. They have been prepared based on the measurement and recognition principles of International Financial Reporting Standards (IFRS) and IFRC interpretations issued and effective at the time of preparing these statements.

 

The financial statements have been prepared under the historical cost convention, as modified by the revaluation of certain assets at fair value, as allowed by IAS39 Financial Instruments: Recognition and Measure.

 

3. Financial risk management

 

3.1 Financial risk factors

 

Sagentia's activities expose it to a variety of financial risks: market risk (including currency risk, fair value interest risk and price risk), credit risk, liquidity risk and cash flow interest-rate risk. Sagentia's overall risk management programme focuses on the unpredictability of financial markets and seeks to minimise potential adverse effects on Sagentia's financial performance.



 

4. Segmental information

 

Sagentia operates one main business segment, being 'Core' operations, which comprises the activities of its Medical and Commercial sectors.  The Group's remaining activities are combined into 'Other' operations.  Core operations include all fees for services work undertaken (excluding IT support services), recharged project materials, and product and licence income.  Other operations include IT support services (and associated recharged project materials) and property income.

 

Period ended 30 June 2012

(Unaudited)

Core

 

£000

Other

 

£000

Total

 

£000

Consulting revenue

8,561

-

8,561

IT support

-

402

402

Property income

-

682

682

Recharged project materials

550

278

828

Product and licence income

178

-

178

Revenue

9,289

1,362

10,651

 

 

 

 

Operating profit

1,913

136

2,049

Share based payments

 

 

(123)

Profit before finance charges and tax

 

 

1,926

Net finance charges

 

 

(117)

Profit before income tax

 

 

1,809

Tax income

 

 

72

Profit for the period from continuing operations

 

 

1,881

 

 

Period ended 30 June 2011

(Unaudited)

Core

 

£000

Other

 

£000

Total

 

£000

Consulting revenue

9,715

-

9,715

IT support

-

402

402

Property income

-

671

671

Recharged project materials

823

246

1,069

Product and licence income

707

-

707

Revenue

11,245

1,319

12,564

 

 

 

 

Operating profit

2,168

82

2,250

Gain on disposal of non-current asset investments

 

 

15

Share based payments

 

 

(104)

Profit before finance charges and tax

 

 

2,161

Net finance charges

 

 

(145)

Profit before income tax

 

 

2,016

Tax income

 

 

20

Profit for the period from continuing operations

 

 

2,036

 

Year ended 31 December 2011

(Audited)

Core

 

£000

Other

 

£000

Total

 

£000

Consulting revenue

18,105

-

18,105

IT support

-

840

840

Property income

-

1,370

1,370

Recharged project materials

1,760

420

2,180

Product and licence income

1,073

-

1,073

Revenue

20,938

2,630

23,568

 

 

 

 

Operating profit

3,604

302

3,906

Loss on disposal of non-current asset investments

 

 

(80)

Share based payments

 

 

(206)

Profit before finance charges and tax

 

 

3,620

Net finance charges

 

 

(274)

Profit before income tax

 

 

3,346

Tax charge

 

 

(78)

Profit for the period from continuing operations

 

 

3,268

 

 

 

5. Earnings per share

 

The calculations of earnings per share are based on the following profits and numbers of shares:

 


Six months

ended

30 June

2012

(Unaudited)

 

£000

Six months

ended

30 June

2011

(Unaudited)

 

£000

Year ended

31

December

2011

(Audited)

 

£000

 

Profit for the financial period from continuing operations

 

1,881

 

2,036

 

3,268

Profit for the financial period (including discontinued operations)

 

1,881

 

2,036

 

2,588

 

 

Weighted average number of shares:

 

Number

 

Number

 

Number

For basic earnings per share

40,934,955

41,723,595

41,733,574

For fully diluted earnings per share

43,942,016

44,666,318

44,666,713

 

 

6. Critical accounting estimates and judgements

 

Estimates and judgements are continually evaluated and are based on historical experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.

 

6.1 Critical accounting estimates and assumptions

 

Sagentia makes estimates and assumptions concerning the future.  The resulting accounting estimates will, by definition, seldom equal the related actual results.  The estimates and assumptions that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year are discussed below.

 

(a) Project accounting

 

Sagentia undertakes a number of fixed price consultancy projects.  The state of completeness of each project, and hence, revenue recognised, requires the use of estimates.  The value of work done is calculated based on proportion of time spent on the project or value of stage gates achieved as set out in the project.

 

(b) Fair value of investments

 

The fair value of unlisted investments held for sale requires the use of estimates and assumptions on both the recoverability and the ability to dispose of the shareholding for value on an individual investment basis.

 

 

- Ends -

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR SFAFMWFESEEW
UK 100

Latest directors dealings